Marijuana Research Today is a free monthly online journal that collates and summarizes the latest research about Marijuana, including details on benefits, cancer, effects, uses, addiction.

Volume 6 (2009), Issue 4 (April)

1. The Mexican migration to the United States and substance use in northern Mexico.
   Addiction, 104(4): 603-11. [Abstract] [Full-text]
2. Fetal ethanol exposure increases ethanol intake by making it smell and taste better.
   Proc Natl Acad Sci U S A, 106(13): 5359-64. [Abstract] [Full-text]
3. The familial aggregation of cannabis use disorders.
   Addiction, 104(4): 622-9. [Abstract] [Full-text]
4. Candidate genes for cannabis use disorders: findings, challenges and directions.
   Addiction, 104(4): 518-32. [Abstract] [Full-text]
5. The effect of cannabis compared with alcohol on driving.
   Am J Addict, 18(3): 185-93. [Abstract] [Full-text]
6. Cannabinoids, endocannabinoids, and related analogs in inflammation.
   AAPS J, 11(1): 109-19. [Abstract] [Full-text]
7. Targeting fatty acid amide hydrolase (FAAH) to treat pain and inflammation.
   AAPS J, 11(1): 39-44. [Abstract] [Full-text]
8. Differential cannabinoid receptor expression during reactive gliosis: a possible implication for a nonpsychotropic neuroprotection.
   ScientificWorldJournal, 9: 229-35. [Abstract] [Full-text]
9. Substance use among road traffic casualties admitted to emergency departments.
   Inj Prev, 15(2): 87-94. [Abstract] [Full-text]
10. Creating REAL MEN: Description of an Intervention to Reduce Drug Use, HIV Risk, and Rearrest Among Young Men Returning to Urban Communities From Jail.
    Health Promot Pract. [Abstract] [Full-text]
11. Biologically Active Cannabinoids from High-Potency Cannabis sativa.
    J Nat Prod. [Abstract] [Full-text]
12. Targeting CB(2) receptors and the endocannabinoid system for the treatment of pain.
    Brain Res Rev, 60(1): 255-66. [Abstract] [Full-text]
13. Modulation of mediotemporal and ventrostriatal function in humans by Delta9-tetrahydrocannabinol: a neural basis for the effects of Cannabis sativa on learning and psychosis.
    Arch Gen Psychiatry, 66(4): 442-51. [Abstract] [Full-text]
14. The short-term safety and efficacy of fluoxetine in depressed adolescents with alcohol and cannabis use disorders: a pilot randomized placebo-controlled trial.
    Child Adolesc Psychiatry Ment Health, 3(1): 11. [Abstract] [Full-text]
15. Predictors of the transition from experimental to daily smoking among adolescents in the United States.
    J Spec Pediatr Nurs, 14(2): 102-11. [Abstract] [Full-text]
16. Health risk behaviours among adolescents in the English-speaking Caribbean: a review.
    Child Adolesc Psychiatry Ment Health, 3(1): 10. [Abstract] [Full-text]
17. Community perceptions of mental health needs: a qualitative study in the Solomon Islands.
    Int J Ment Health Syst, 3(1): 6. [Abstract] [Full-text]
18. Substance abuse and child maltreatment.
    Pediatr Clin North Am, 56(2): 345-62. [Abstract] [Full-text]
19. The challenges in developing a rational cannabis policy.
    Curr Opin Psychiatry, 22(3): 258-62. [Abstract] [Full-text]
20. Marijuana and chronic obstructive lung disease: a population-based study.
    CMAJ, 180(8): 814-20. [Abstract] [Full-text]
21. Cannabinoids and appetite: food craving and food pleasure.
    Int Rev Psychiatry, 21(2): 163-71. [Abstract] [Full-text]
22. Cannabinoids and psychosis.
    Int Rev Psychiatry, 21(2): 152-62. [Abstract] [Full-text]
23. Basic neuroanatomy and neuropharmacology of cannabinoids.
    Int Rev Psychiatry, 21(2): 113-21. [Abstract] [Full-text]
24. Actions of delta-9-tetrahydrocannabinol in cannabis: relation to use, abuse, dependence.
    Int Rev Psychiatry, 21(2): 104-12. [Abstract] [Full-text]
25. Cannabis use disorder: epidemiology and management.
    Int Rev Psychiatry, 21(2): 96-103. [Abstract] [Full-text]
26. Cannabinoids for the treatment of dementia.
    Cochrane Database Syst Rev. [Abstract] [Full-text]
27. Pubertal timing, friend smoking, and substance use in adolescent girls.
    Prev Sci, 10(2): 141-50. [Abstract] [Full-text]
28. Social anxiety disorder and marijuana use problems: the mediating role of marijuana effect expectancies.
    Depress Anxiety. [Abstract] [Full-text]
29. Prenatal cocaine exposure and prolonged focus attention. Poor infant information processing ability or precocious maturation of attentional systems?
    Dev Neurosci, 31(1): 149-58. [Abstract] [Full-text]
30. Marijuana effectiveness as an HIV self-care strategy.
    Clin Nurs Res, 18(2): 172-93. [Abstract] [Full-text]
31. Prevalence of psychotic symptoms in substance users: a comparison across substances.
    Compr Psychiatry, 50(3): 245-50. [Abstract] [Full-text]
32. Cognitive and psychomotor effects in males after smoking a combination of tobacco and cannabis containing up to 69 mg delta-9-tetrahydrocannabinol (THC).
    Psychopharmacology (Berl), 204(1): 85-94. [Abstract] [Full-text]
33. Patterns of adolescent physical activity, screen-based media use, and positive and negative health indicators in the U.S. and Canada.
    J Adolesc Health, 44(5): 493-9. [Abstract] [Full-text]
34. Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users.
    J Psychopharmacol, 23(3): 266-77. [Abstract] [Full-text]
35. Reliability and validity of a short form of the Marijuana Craving Questionnaire.
    Drug Alcohol Depend, 102(1): 35-40. [Abstract] [Full-text]
36. Neurobehavior disinhibition, parental substance use disorder, neighborhood quality and development of cannabis use disorder in boys.
    Drug Alcohol Depend, 102(1): 71-7. [Abstract] [Full-text]
37. Common genetic influences on the timing of first use for alcohol, cigarettes, and cannabis in young African-American women.
    Drug Alcohol Depend, 102(1): 49-55. [Abstract] [Full-text]
38. Developmental epidemiology of drug use and abuse in adolescence and young adulthood: Evidence of generalized risk.
    Drug Alcohol Depend, 102(1): 78-87. [Abstract] [Full-text]
39. Decision-making in long-term cocaine users: Effects of a cash monetary contingency on Gambling task performance.
    Drug Alcohol Depend, 102(1): 95-101. [Abstract] [Full-text]
40. The influence of program mediators on eleventh grade outcomes for seventh grade substance users and nonusers.
    Drug Alcohol Depend, 102(1): 11-8. [Abstract] [Full-text]
41. The Adolescent Substance Abuse Prevention Study: A randomized field trial of a universal substance abuse prevention program.
    Drug Alcohol Depend, 102(1): 1-10. [Abstract] [Full-text]
42. Opportunities to use drugs and stages of drug involvement outside the United States: Evidence from the Republic of Chile.
    Drug Alcohol Depend, 102(1): 30-4. [Abstract] [Full-text]
43. Alcohol, illicit and non-illicit psychoactive drug use and road traffic injury in Thailand: a case-control study.
    Accid Anal Prev, 41(3): 651-7. [Abstract] [Full-text]
44. Evaluation of principal cannabinoids in airborne particulates.
    Anal Chim Acta, 641(1): 89-94. [Abstract] [Full-text]
45. A typology of cannabis-related problems among individuals with repeated illegal drug use in the first three decades of life: Evidence for heterogeneity and different treatment needs.
    Drug Alcohol Depend, 102(1): 151-7. [Abstract] [Full-text]
46. Universal school-based substance abuse prevention programs: Modeling targeted mediators and outcomes for adolescent cigarette, alcohol and marijuana use.
    Drug Alcohol Depend, 102(1): 19-29. [Abstract] [Full-text]
47. Heavy vehicle driver fatalities: learning's from fatal road crash investigations in Victoria.
    Accid Anal Prev, 41(3): 557-64. [Abstract] [Full-text]
48. Prevalence of psychoactive drug use among drivers in Thailand: a roadside survey.
    Accid Anal Prev, 41(3): 474-8. [Abstract] [Full-text]
49. Psychomotor performance in relation to acute oral administration of Delta9-tetrahydrocannabinol and standardized cannabis extract in healthy human subjects.
    Eur Arch Psychiatry Clin Neurosci, 259(5): 284-92. [Abstract] [Full-text]
50. Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders.
    Phytother Res, 23(5): 597-602. [Abstract] [Full-text]
51. Morbidity in a Population of Low-Income, Female Users of MDMA and Other Drugs.
    Subst Use Misuse. [Abstract] [Full-text]

© 2004-2013 Marijuana Research Today. All Rights Reserved.